{"entity":{"type":"insider","cik":"0001465822","url":"/insider/0001465822","json_url":"/insider/0001465822.json","name":"NARINE JEENARINE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":21,"first":"2011-03-16","last":"2015-05-13","span_basis":"filed_date"},"name_variants":[{"name":"NARINE JEENARINE","source":"filing","n_filings":21,"first_seen":"2011-03-16","last_seen":"2015-05-13"}],"transactions":[{"id":7089404,"accession":"0001465822-14-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465822-14-000001","line_url":"/filing/0001465822-14-000001#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329437.0,"shares_display":"329,437","price_per_share":0.3823,"price_display":"0.38","price_state":"stated","total_value":125943.7651,"total_display":"125,943.77","shares_owned_after":5510455.0,"shares_owned_after_display":"5,510,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-09","filed_date":"2014-05-13","scope":"insider"},{"id":9218468,"accession":"0001053369-15-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001053369-15-000031","line_url":"/filing/0001053369-15-000031#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":147667.0,"shares_display":"147,667","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":60543.47,"total_display":"60,543.47","shares_owned_after":5682877.0,"shares_owned_after_display":"5,682,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-02","filed_date":"2015-05-13","scope":"insider"},{"id":6570235,"accession":"0001053369-14-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000029","line_url":"/filing/0001053369-14-000029#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":147664.0,"shares_display":"147,664","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":60542.24,"total_display":"60,542.24","shares_owned_after":5839892.0,"shares_owned_after_display":"5,839,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-02","filed_date":"2014-04-04","scope":"insider"},{"id":9218469,"accession":"0001053369-15-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-15-000031","line_url":"/filing/0001053369-15-000031#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157012.0,"shares_display":"157,012","price_per_share":0.4116,"price_display":"0.41","price_state":"stated","total_value":64626.1392,"total_display":"64,626.14","shares_owned_after":5830544.0,"shares_owned_after_display":"5,830,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2015-05-13","scope":"insider"},{"id":6956497,"accession":"0001053369-14-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000028","line_url":"/filing/0001053369-14-000028#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190172.0,"shares_display":"190,172","price_per_share":0.4268,"price_display":"0.43","price_state":"stated","total_value":81165.4096,"total_display":"81,165.41","shares_owned_after":5987556.0,"shares_owned_after_display":"5,987,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-27","filed_date":"2014-03-31","scope":"insider"},{"id":6361204,"accession":"0001053369-14-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000027","line_url":"/filing/0001053369-14-000027#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239367.0,"shares_display":"239,367","price_per_share":0.6016,"price_display":"0.60","price_state":"stated","total_value":144003.1872,"total_display":"144,003.19","shares_owned_after":14887229.0,"shares_owned_after_display":"14,887,229","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-11","filed_date":"2014-03-17","scope":"insider"},{"id":6623746,"accession":"0001465826-14-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001465826-14-000004","line_url":"/filing/0001465826-14-000004#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1051450.0,"shares_display":"1,051,450","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":714986.0,"total_display":"714,986.00","shares_owned_after":14939890.0,"shares_owned_after_display":"14,939,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-10","scope":"insider"},{"id":6623742,"accession":"0001465826-14-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465826-14-000004","line_url":"/filing/0001465826-14-000004#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":773050.0,"shares_display":"773,050","price_per_share":0.8956,"price_display":"0.90","price_state":"stated","total_value":692343.58,"total_display":"692,343.58","shares_owned_after":15171209.0,"shares_owned_after_display":"15,171,209","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-10","scope":"insider"},{"id":6544601,"accession":"0001053369-14-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000014","line_url":"/filing/0001053369-14-000014#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":805583.0,"shares_display":"805,583","price_per_share":0.183,"price_display":"0.18","price_state":"stated","total_value":147421.689,"total_display":"147,421.69","shares_owned_after":15341280.0,"shares_owned_after_display":"15,341,280","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-13","filed_date":"2014-01-17","scope":"insider"},{"id":5183036,"accession":"0001442002-13-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001442002-13-000003","line_url":"/filing/0001442002-13-000003#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275000.0,"shares_display":"275,000","price_per_share":0.1255,"price_display":"0.13","price_state":"stated","total_value":34512.5,"total_display":"34,512.50","shares_owned_after":15621069.0,"shares_owned_after_display":"15,621,069","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-05","filed_date":"2013-12-13","scope":"insider"},{"id":5496617,"accession":"0001053369-13-000058","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001053369-13-000058","line_url":"/filing/0001053369-13-000058#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.1212,"price_display":"0.12","price_state":"stated","total_value":3030.0,"total_display":"3,030.00","shares_owned_after":15708769.0,"shares_owned_after_display":"15,708,769","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-27","filed_date":"2013-11-29","scope":"insider"},{"id":5496616,"accession":"0001053369-13-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001053369-13-000058","line_url":"/filing/0001053369-13-000058#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357000.0,"shares_display":"357,000","price_per_share":0.1208,"price_display":"0.12","price_state":"stated","total_value":43125.6,"total_display":"43,125.60","shares_owned_after":15714268.0,"shares_owned_after_display":"15,714,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-11-29","scope":"insider"},{"id":5183027,"accession":"0001442002-13-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001442002-13-000003","line_url":"/filing/0001442002-13-000003#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23626.0,"shares_display":"23,626","price_per_share":0.1182,"price_display":"0.12","price_state":"stated","total_value":2792.5932,"total_display":"2,792.59","shares_owned_after":15681569.0,"shares_owned_after_display":"15,681,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-12-13","scope":"insider"},{"id":5217108,"accession":"0001465826-13-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001465826-13-000004","line_url":"/filing/0001465826-13-000004#line-4","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":0.119,"price_display":"0.12","price_state":"stated","total_value":2499.0,"total_display":"2,499.00","shares_owned_after":15801388.0,"shares_owned_after_display":"15,801,388","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-19","scope":"insider"},{"id":5217103,"accession":"0001465826-13-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001465826-13-000004","line_url":"/filing/0001465826-13-000004#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1170000.0,"shares_display":"1,170,000","price_per_share":0.1175,"price_display":"0.12","price_state":"stated","total_value":137475.0,"total_display":"137,475.00","shares_owned_after":15806008.0,"shares_owned_after_display":"15,806,008","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-19","scope":"insider"},{"id":9218465,"accession":"0001053369-14-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000004","line_url":"/filing/0001053369-14-000004#line-1","is_derivative":false,"issuer_cik":"0001465822","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001465822","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":253050.0,"shares_display":"253,050","price_per_share":0.1173,"price_display":"0.12","price_state":"stated","total_value":29682.765,"total_display":"29,682.76","shares_owned_after":16049109.0,"shares_owned_after_display":"16,049,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2014-01-06","scope":"insider"},{"id":5217100,"accession":"0001465826-13-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001465826-13-000004","line_url":"/filing/0001465826-13-000004#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318050.0,"shares_display":"318,050","price_per_share":0.1173,"price_display":"0.12","price_state":"stated","total_value":37307.265,"total_display":"37,307.26","shares_owned_after":16063408.0,"shares_owned_after_display":"16,063,408","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider"},{"id":5217093,"accession":"0001465826-13-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465826-13-000004","line_url":"/filing/0001465826-13-000004#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":465090.0,"shares_display":"465,090","price_per_share":0.1152,"price_display":"0.12","price_state":"stated","total_value":53578.368,"total_display":"53,578.37","shares_owned_after":16133379.0,"shares_owned_after_display":"16,133,379","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-14","filed_date":"2013-11-19","scope":"insider"},{"id":5496614,"accession":"0001053369-13-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000058","line_url":"/filing/0001053369-13-000058#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39000.0,"shares_display":"39,000","price_per_share":0.1225,"price_display":"0.12","price_state":"stated","total_value":4777.5,"total_display":"4,777.50","shares_owned_after":15792808.0,"shares_owned_after_display":"15,792,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-11","filed_date":"2013-11-29","scope":"insider"},{"id":5526140,"accession":"0001053369-13-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000054","line_url":"/filing/0001053369-13-000054#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122200.0,"shares_display":"122,200","price_per_share":0.1235,"price_display":"0.12","price_state":"stated","total_value":15091.7,"total_display":"15,091.70","shares_owned_after":16235699.0,"shares_owned_after_display":"16,235,699","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-06","filed_date":"2013-11-08","scope":"insider"},{"id":4909217,"accession":"0001053369-13-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001053369-13-000050","line_url":"/filing/0001053369-13-000050#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102520.0,"shares_display":"102,520","price_per_share":0.0127,"price_display":"0.01","price_state":"stated","total_value":1302.004,"total_display":"1,302.00","shares_owned_after":16262583.0,"shares_owned_after_display":"16,262,583","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-10-30","scope":"insider"},{"id":4909216,"accession":"0001053369-13-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000050","line_url":"/filing/0001053369-13-000050#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102300.0,"shares_display":"102,300","price_per_share":0.1295,"price_display":"0.13","price_state":"stated","total_value":13247.85,"total_display":"13,247.85","shares_owned_after":16365103.0,"shares_owned_after_display":"16,365,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-28","filed_date":"2013-10-30","scope":"insider"},{"id":4332001,"accession":"0001053369-13-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000011","line_url":"/filing/0001053369-13-000011#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":356700.0,"shares_display":"356,700","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":32103.0,"total_display":"32,103.00","shares_owned_after":13303884.0,"shares_owned_after_display":"13,303,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-22","filed_date":"2013-01-25","scope":"insider"},{"id":5526128,"accession":"0001053369-13-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000004","line_url":"/filing/0001053369-13-000004#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2339000.0,"shares_display":"2,339,000","price_per_share":0.0906,"price_display":"0.09","price_state":"stated","total_value":211913.4,"total_display":"211,913.40","shares_owned_after":7628584.0,"shares_owned_after_display":"7,628,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-11","filed_date":"2013-01-14","scope":"insider"},{"id":7025960,"accession":"0001053369-14-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000010","line_url":"/filing/0001053369-14-000010#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":531185.0,"shares_display":"531,185","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":79677.75,"total_display":"79,677.75","shares_owned_after":15518508.0,"shares_owned_after_display":"15,518,508","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2014-01-07","scope":"insider"},{"id":2480865,"accession":"0001053369-12-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-12-000012","line_url":"/filing/0001053369-12-000012#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":561000.0,"shares_display":"561,000","price_per_share":0.0907,"price_display":"0.09","price_state":"stated","total_value":50882.7,"total_display":"50,882.70","shares_owned_after":9967584.0,"shares_owned_after_display":"9,967,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-26","filed_date":"2012-12-31","scope":"insider"},{"id":3054121,"accession":"0001053369-12-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-12-000006","line_url":"/filing/0001053369-12-000006#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243300.0,"shares_display":"243,300","price_per_share":0.0918,"price_display":"0.09","price_state":"stated","total_value":22334.94,"total_display":"22,334.94","shares_owned_after":27534004.0,"shares_owned_after_display":"27,534,004","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-21","scope":"insider"},{"id":3378008,"accession":"0001345568-12-000023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001345568-12-000023","line_url":"/filing/0001345568-12-000023#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":735000.0,"shares_display":"735,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":66150.0,"total_display":"66,150.00","shares_owned_after":61273251.0,"shares_owned_after_display":"61,273,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-27","filed_date":"2012-03-27","scope":"insider"},{"id":3378007,"accession":"0001345568-12-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001345568-12-000023","line_url":"/filing/0001345568-12-000023#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225000.0,"shares_display":"225,000","price_per_share":0.0947,"price_display":"0.09","price_state":"stated","total_value":21307.5,"total_display":"21,307.50","shares_owned_after":62008251.0,"shares_owned_after_display":"62,008,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-26","filed_date":"2012-03-27","scope":"insider"},{"id":3378005,"accession":"0001345568-12-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001345568-12-000023","line_url":"/filing/0001345568-12-000023#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1765000.0,"shares_display":"1,765,000","price_per_share":0.0958,"price_display":"0.10","price_state":"stated","total_value":169087.0,"total_display":"169,087.00","shares_owned_after":62233251.0,"shares_owned_after_display":"62,233,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-27","scope":"insider"},{"id":2354900,"accession":"0001345568-12-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001345568-12-000012","line_url":"/filing/0001345568-12-000012#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85000.0,"shares_display":"85,000","price_per_share":0.1005,"price_display":"0.10","price_state":"stated","total_value":8542.5,"total_display":"8,542.50","shares_owned_after":63766618.0,"shares_owned_after_display":"63,766,618","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-16","filed_date":"2012-03-20","scope":"insider"},{"id":9108549,"accession":"0001126562-11-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001126562-11-000007","line_url":"/filing/0001126562-11-000007#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465822","owner_name":"NARINE JEENARINE","owner_url":"/insider/0001465822","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":407949.0,"shares_display":"407,949","price_per_share":0.04,"price_display":"0.04","price_state":"stated","total_value":16317.96,"total_display":"16,317.96","shares_owned_after":407949.0,"shares_owned_after_display":"407,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-03","filed_date":"2011-03-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001053369","name":"ELITE PHARMACEUTICALS INC /NV/","url":"/issuer/0001053369","role":"Director, Ten percent owner","n_filings":21,"first_seen":"2011-03-16","last_seen":"2015-05-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001465822","retrieved_at":"2026-08-22T03:12:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}